Medicare Enrolled
Dr. Ana Cristina Laureano, M.D.
Dermatology · Fair Lawn, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Laureano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laureano?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Laureano
Dr. Ana Cristina Laureano is a dermatology specialist in Fair Lawn, NJ, with 14 years of NPI registration. Based on federal Medicare data, Dr. Laureano performed 2,279 Medicare services across 1,353 unique beneficiaries.
Between the years covered by Open Payments, Dr. Laureano received a total of $14,472 from 48 pharmaceutical and/or device companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Laureano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ 2,279 Medicare services
$14,472 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,279
Medicare services
Bottom 45% in NJ for dermatology
1,353
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~163 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
646 | $73 | $301 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
605 | $6 | $25 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
224 | $50 | $235 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
171 | $84 | $357 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
142 | $12 | $52 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $46 | $191 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
114 | $85 | $371 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $104 | $403 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
70 | $101 | $405 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
35 | $1 | $3 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
30 | $33 | $199 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
23 | $47 | $176 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
12 | $85 | $434 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,472
Total received (2018-2024)
Avg $2,067/year across 7 years
Top 14% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
971
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,130 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$343 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,767
2023
$3,022
2022
$2,064
2021
$2,065
2020
$1,613
2019
$1,767
2018
$1,175
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$478
Lilly USA, LLC
$422
ABBVIE INC.
$323
GENZYME CORPORATION
$313
Janssen Biotech, Inc.
$248
Regeneron Healthcare Solutions, Inc.
$182
Ortho Dermatologics, a division of Bausch Health US, LLC
$180
Arcutis Biotherapeutics, Inc.
$154
Amgen Inc.
$105
SUN PHARMACEUTICAL INDUSTRIES INC.
$89
E.R. Squibb & Sons, L.L.C.
$68
UCB, Inc.
$61
Dermavant Sciences, Inc.
$46
Galderma Laboratories, L.P.
$34
LEO Pharma Inc.
$33
Incyte Corporation
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,210
Janssen Biotech, Inc.
$1,186
PFIZER INC.
$1,007
Ortho Dermatologics, a division of Bausch Health US, LLC
$959
GENZYME CORPORATION
$942
ABBVIE INC.
$821
LEO Pharma Inc.
$788
Sun Pharmaceutical Industries Inc.
$783
Galderma Laboratories, L.P.
$748
Amgen Inc.
$633
Regeneron Healthcare Solutions, Inc.
$560
Novartis Pharmaceuticals Corporation
$424
MAYNE PHARMA INC.
$375
AbbVie Inc.
$333
Arcutis Biotherapeutics, Inc.
$316
Genentech USA, Inc.
$313
Dermavant Sciences, Inc.
$302
E.R. Squibb & Sons, L.L.C.
$296
Janssen Scientific Affairs, LLC
$238
VYNE Pharmaceuticals Inc.
$207
Almirall LLC
$204
Mayne Pharma Inc.
$195
SUN PHARMACEUTICAL INDUSTRIES INC.
$189
Celgene Corporation
$187
EPI Health, LLC
$174
UCB, Inc.
$159
Journey Medical Corporation
$154
Biofrontera Inc.
$132
AbbVie, Inc.
$106
Incyte Corporation
$66
Sandoz Inc.
$62
DERMIRA, INC.
$58
Promius Pharma LLC
$43
Encore Dermatology Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Helsinn Therapeutics (U.S.), Inc.
$31
Sebela Pharmaceuticals Inc.
$30
DUSA Pharmaceuticals, Inc.
$29
Taro Pharmaceuticals USA, Inc.
$15
Aclaris Therapeutics, Inc.
$15
OraPharma, a division of Bausch Health US, LLC
$15
Exeltis, USA Inc.
$15
Kyowa Kirin, Inc.
$15
TARO PHARMACEUTICALS USA, INC.
$14
Glenmark Therapeutics Inc.
$14
Solta Medical, a division of Bausch Health US, LLC
$14
SANOFI-AVENTIS U.S. LLC
$13
Pierre Fabre Pharmaceuticals, Inc.
$12
Top 3 companies account for 23.5% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMZEEQ · APEXICON E · ARAZLO · ARESTIN · Absorica LD · Aczone · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Cordran Tape · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Erivedge · FINACEA · HALOG (Halcinonide Cream · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · LUZU LULICONAZOLE · Mupirocin Cream · NAFTIN · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · OXISTAT · Otezla · PICATO · POTELIGEO · PRAMOSONE · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TargaDox · Tremfya · ULTRAVATE · USP) 0.1% · VALCHLOR · VTAMA · Winlevi · XIMINO · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
922
Per 100K population
96.6
County median income
$123,715
Nearest hospital
VALLEY HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Laureano is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of NJ peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Laureano experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Laureano performed 646 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laureano receive payments from pharmaceutical companies?
Yes. Dr. Laureano received a total of $14,472 from 48 companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laureano's costs compare to other dermatologists in Fair Lawn?
Dr. Laureano's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laureano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Fair Lawn
Browse dermatologists in Fair Lawn ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NJ
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NJ
Which NJ dermatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology